secwatch.observer — SEC 8-K summary
======================================

Issuer:     TerrAscend Corp. (TSNDF)
CIK:        0001778129
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001193125-26-210379
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TerrAscend Q1 2026: revenue $65.5M, adj EBITDA $17.4M, 15th consecutive positive cash flow
--------------------------------------------------------------------------------

- Net revenue $65.5M, +1.9% YoY; gross margin 52.8% vs 53.9% a year ago.
- GAAP net loss from cont ops $6.8M vs $7.7M YoY; Adj EBITDA $17.4M (26.5% margin).
- Net cash from cont ops $8.7M; free cash flow $7.8M; 15th straight quarter positive ops cash flow.
- U.S. medical cannabis rescheduled to Schedule III post-quarter, eliminating 280E tax on medical cannabis.
- Appointed Eric Jackson as CFO effective April 2026; executed NCIB repurchases of 115k shares at ~$0.66.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1778129/000119312526210379/0001193125-26-210379-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1778129/000119312526210379/tsndf-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-210379

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer